Warning letter
Walgreen Company: warning letter of Sep 12, 2023
FDA warning letter 662158 · Center for Drug Evaluation and Research | CDER
Key facts
| Reference number | 662158 |
|---|---|
| Company | Walgreen Company |
| Subject | Failure to Register and List |
| Issue date | Sep 12, 2023 |
| Posted date | Sep 19, 2023 |
| Issuing office | Center for Drug Evaluation and Research | CDER |
| Product type | Drugs |
| CFR sections cited | 207.57(b)(2), 207, 207.49(a)(4), 207.33(c) |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: